Which stocks have an unusual volume on Tuesday?
By Mill Chart
Last update: Jun 28, 2022
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the stocks with an unusual volume in today's session.
Unusual volume stocks
| Ticker | Change | Comment |
|---|---|---|
| BNTC | -5.19% | So far 10.49M shares of Benitec Biopharma Limited (NASDAQ:BNTC) have traded in today's session. The share price decreased by 5.19%. The average daily volume over 50 days is 2.44M, so this is 329.0% above the average volume. |
| NRSN | 0.0% | NeuroSense Therapeutics Ltd (NASDAQ:NRSN) has an unusual volume of 3.5M shares today. This is 57.43% above the average daily volume of the last 50 days. |
| FEMY | 2.48% | 2.5M shares of Femasys Inc (NASDAQ:FEMY) have been traded so far today. NASDAQ:FEMY is advancing 2.48% today. The average daily volume over 50 days is 326.28K, so this is 668.0% above the average volume. |
| AFIB | -3.06% | Acutus Medical Inc (NASDAQ:AFIB) has an unusual volume of 8.32M shares today. Leading to a price decrease of 3.06%. This is 62.14% above the average daily volume of the last 50 days. |
| VIVE | -3.57% | Viveve Medical Inc's (NASDAQ:VIVE) traded a high volume of 403.02K shares. The share price decreased by 3.57%. This is 121.0% above the average daily volume of the last 50 days. |
| AGRX | 65.98% | 173.93M shares of Agile Therapeutics Inc (NASDAQ:AGRX) exchanged hands today. The share price increased by 65.98%. The average daily volume over 50 days is 6.05M, so this is 3.0K% above the average volume. |
| RDHL | -10.28% | Redhill Boipharma Ltd's (NASDAQ:RDHL) traded a high volume of 4.87M shares. The share price decreased by 10.28%. The average volume measured over 50 days is 2.24M, so this is 117.0% above the average volume. |
| ATHA | -2.46% | 1.07M shares of Athira Pharma Inc (NASDAQ:ATHA) exchanged hands today. NASDAQ:ATHA is declining 2.46% today. The average daily volume over 50 days is 871.25K, so this is 23.13% above the average volume. |
| EVFM | 6.53% | Evofem Biosciences Inc's (NASDAQ:EVFM) traded a high volume of 260.29M shares. The share price increased by 6.53%. This volume is 2.0K% above the average 50 day volume. |
| DTIL | -9.67% | 6.3M shares of Precision BioSciences Inc (NASDAQ:DTIL) exchanged hands today. NASDAQ:DTIL is declining 9.67% today. This volume is 153.0% above the average 50 day volume. Earlier today the company had a press release: Global Pancreatic Cancer Therapeutics & Diagnostics Market Expected To Reach $5.6 Billion By 2027. |
Our unusual volume stocks screener will show you the full list.
REDHILL BIOPHARMA LTD-SP ADR
NASDAQ:RDHL (4/18/2024, 7:17:03 PM)
After market: 0.4199 0 (-0.21%)0.4208
+0.04 (+9.16%)
RDHL News
10 days ago - RedHill Biopharma Ltd.RedHill Biopharma Announces Full-Year 2023 Results and Operational HighlightsRedHill continues corporate transformation to focus on U.S. government-funded pipeline development in underserved, sizeable therapeutic areas with a...
17 days ago - RedHill Biopharma Ltd.RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered...
a month ago - RedHill Biopharma Ltd.RedHill Announces New USPTO Patent Covering Talicia® Through 2034U.S. Patent and Trademark Office (USPTO) issues new patent covering Talicia1 as an all-in-one treatment of Helicobacter pylori (H. pylori), supporting Talicia...
a month ago - RedHill Biopharma Ltd.RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures ProgramsThe U.S. government's Chemical Medical Countermeasures (Chem MCM) Program and Chemical Countermeasures Research Program (CCRP), managed respectively by...
2 months ago - Seeking AlphaRedHill Biopharma files to sell 10.6M ADS for holders (NASDAQ:RDHL)Read about RedHill Biopharma's filing of a prospectus for the resale of 10.6M ADSs, representing 400 shares each, by selling stockholders.
3 months ago - RedHill Biopharma Ltd.RedHill Biopharma Announces Closing of $8 Million Registered Direct Offering/PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has closed...
3 months ago - RedHill Biopharma Ltd.RedHill Biopharma Announces $8 Million Registered Direct Offering/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered...
3 months ago - Seeking AlphaRedHill gains on patent grant for Talicia for H. pylori treatment (NASDAQ:RDHL)RedHill Biopharma's new patent for Talicia, a method for eradicating H.
3 months ago - RedHill Biopharma Ltd.RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042USPTO issues new patent covering Talicia[1] as a method for eradicating H. pylori regardless of patient Body Mass Index (BMI)[2], supporting Talicia protection...
